Overactive bladder syndrome with and without urinary incontinence and related conditions,
signs, and disorders such as detrusor overactivity, neurogenic lower urinary tract …

Since its regulatory approval over a half-century ago, botulinum toxin has evolved from one
of the most potent neurotoxins known to becoming routinely adopted in clinical practice …

Onabotulinum toxin type A (BTX A) is widely used as cystoscopic injections as third-line
treatments for idiopathic urinary urgency/frequency otherwise known as overactive bladder …

Detrusor injections of botulinum toxin A (BTX-A), one of the seven subtypes of the neurotoxin
produced by the Clostridium botulinum, changed the management of neurogenic detrusor …